EUROFARMACJA + SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
EUROFARMACJA + SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
B
HighReliability
B - HighIncorporation date
11/10/2016Share capital
5,000.00 PLNPrimary activity
Dispensing chemist in specialized stores (47.73.Z - PKD 2007)Representatives
0Representatives rights
W PRZYPADKU GDY ZARZĄD JEST WIELOOSOBOWY , DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU LUB JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM. W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO SPÓŁKĘ REPREZENTUJE PREZES ZARZĄDU SAMODZIELNIE.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
897,973Net Profit (zł)
897,973Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 21,446,618 |
| 1,099,368 |
| 909,639 |
| 0.02 |
| 1.11 |
| 4.24 |
| 962,494 |
| 3,683,702 |
| - |
| 685,841 |
| 2023 |
|---|
| 22,277,813 |
| 444,090 |
| 353,244 |
| 0.05 |
| 1.25 |
| 1.59 |
| 1,315,738 |
| 4,204,600 |
| - |
| 527,294 |
| 2024 |
|---|
| 23,703,286 |
| 1,088,839 |
| 897,973 |
| 0.07 |
| 1.41 |
| 3.79 |
| 2,213,712 |
| 4,218,972 |
| - |
| 771,347 |
| 2024 |
|---|
| 23,703,286 |
| 1,088,839 |
| 897,973 |
| 0.07 |
| 1.41 |
| 3.79 |
| 2,213,712 |
| 4,218,972 |
| - |
| 771,347 |
Turnover (zł)
2024
Turnover (zł)
23,703,286 zł
6 % *
Profit before tax (zł)
1,088,839 zł145 % *
Net Profit (zł)
897,973 zł154 % *
Working capital requirement (%)
0.07 
40.00 % *
Liquidity ratio
1.41 12.80 % *
Net profitability (%)
3.79 %138.36 % *
Equity (zł)
2,213,712 zł68 % *
Current liabilities (zł)
4,218,972 zł0 % *
Non current liabilities (zł)
-Non-current Assets (zł)
771,347 zł
46 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
EUROFARMACJA + SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
08/07/2025 | OD 01.01.2024 DO 31.12.2024 |
14/07/2024 | OD 01.01.2023 DO 31.12.2023 |
28/08/2023 | OD 01.01.2022 DO 31.12.2022 |
21/09/2022 | OD 01.01.2021 DO 31.12.2021 |
14/09/2021 | OD 01.01.2020 DO 31.12.2020 |